EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieStudienprotokoll

Development of PRECISE, a Data-Driven Personalized Suicide Prevention Intervention: Protocol for an Intervention Refinement Pilot and Randomized Controlled Trial

Kevin Kuehn iD, Raeanne Moore iD, Katherine T Foster iD, Colin Depp iD

JMIR Research Protocols · 18.11.2026 · 15 · e109277

DOI: 10.2196/109277 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift JMIR Research Protocols, online erschienen am 18.11.2026. Verfasst von Kevin Kuehn und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Psychiatry, School of Medicine, University of California San Diego, La Jolla, CA, United States. Hauptthemen laut MEDLINE: Suicide Prevention, Precision Medicine, Dialectical Behavior Therapy. Die Arbeit nennt 58 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Suicidal thoughts and behaviors (STBs) are heterogeneous in their causes and course, yet most interventions rely on nomothetic, one-size-fits-all models. Dialectical behavior therapy (DBT) is an evidence-based treatment for STBs, but its standard year-long format is resource-intensive and difficult to access. Ecological momentary assessment (EMA) combined with idiographic (person-specific) statistical modeling offers a way to identify which emotion regulation processes are driving an individual’s risk, and in turn to select the DBT skills most relevant for that person.

Objective

This protocol describes the refinement (aim 1) and preliminary evaluation (aim 2) of PRECISE (Personalized Clinical Intervention for Suicidal Events), an 8-week, EMA-informed, idiographically tailored adjunctive treatment for adults with active suicidal ideation.

Methods

In aim 1, an existing PRECISE treatment manual and clinician dashboard will be iteratively refined with a mentorship and advisory panel and tested for feasibility and acceptability in a small, randomized pilot study (n=10; n=5 per arm), comparing high- and low-intensity personalization schedules. In aim 2, 60 adults with active suicidal ideation will be randomized to a high-intensity (weekly idiographic model updates across all 8 EMA-monitored weeks) or low-intensity (single idiographic model generated after an initial 2-week EMA burst) version of PRECISE. Both arms will receive coach-delivered DBT skills selected according to each participant’s idiographic model, which will be generated using the group iterative multiple model estimation (GIMME) algorithm. Primary outcomes include usability, retention, EMA adherence, acceptability, and fidelity; secondary and exploratory analyses will examine trajectories of suicidal ideation and a within-person mediation model linking emotion regulation to STBs.

Results

The trial registration record (ClinicalTrials.gov) was first posted on February 5, 2025, and enrollment began on November 14, 2025. The study is currently recruiting. Estimated total enrollment across aim 1 and aim 2 is 70 participants. Primary and final data collection are anticipated to be complete by March 2030. The study was funded in May 2025, and data collection began in November 2025. As of November 9, 2026, 7 participants had been enrolled. Results are expected to be published in approximately the beginning of 2030.

Conclusions

PRECISE is, to our knowledge, the first idiographically personalized, EMA-informed adjunctive treatment developed specifically for STBs. This trial will provide feasibility, acceptability, and preliminary efficacy data to inform a subsequent fully powered efficacy trial. Trial Registration ClinicalTrials.gov NCT06809348; https://clinicaltrials.gov/study/NCT06809348 International Registered Report Identifier (IRRID) DERR1-10.2196/109277

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Suicide PreventionPrecision MedicineDialectical Behavior TherapyHumansPilot ProjectsSuicidal IdeationAdultEcological Momentary AssessmentResearch DesignRandomized Controlled Trials as Topic

Stichwörter der Autor:innen

dialectical behavior therapydigital healthecological momentary assessmentidiographicpersonalized interventionrandomized controlled trial protocolsuicide prevention

Autor:innen und Institutionen

  • Department of Psychiatry, School of Medicine, University of California San Diego, La Jolla, CA, United States.
  • Department of Psychology, Department of Global Health, University of Washington, Seattle, WA, United States.

ORCID-Profile: Kevin Kuehn, Raeanne Moore, Katherine T Foster, Colin Depp

Zitieren

APA

Kuehn, K., Moore, R., Foster, K. T., & Depp, C. (2026). Development of PRECISE, a Data-Driven Personalized Suicide Prevention Intervention: Protocol for an Intervention Refinement Pilot and Randomized Controlled Trial. JMIR Research Protocols, 15, e109277. https://doi.org/10.2196/109277

Vancouver

Kuehn K, Moore R, Foster KT, Depp C. Development of PRECISE, a Data-Driven Personalized Suicide Prevention Intervention: Protocol for an Intervention Refinement Pilot and Randomized Controlled Trial. JMIR Research Protocols. 2026;15:e109277. doi:10.2196/109277

BibTeX
@article{Kuehn2026,
  author = {Kuehn, Kevin and Moore, Raeanne and Foster, Katherine T and Depp, Colin},
  title = {Development of PRECISE, a Data-Driven Personalized Suicide Prevention Intervention: Protocol for an Intervention Refinement Pilot and Randomized Controlled Trial},
  journal = {JMIR Research Protocols},
  year = {2026},
  volume = {15},
  pages = {e109277},
  doi = {10.2196/109277}
}
Kostenlos starten →